Usefulness of a clinical risk score to predict the response to cardiac resynchronization therapy.
暂无分享,去创建一个
P. Lambiase | L. Fauchier | É. Marijon | C. Leclercq | J. Deharo | A. Chow | R. Providência | S. Boveda | D. Gras | O. Segal | P. Bordachar | O. Piot | S. Barra | S. Agarwal | S. Winnik | P. Defaye | A. Breitenstein | J. Steffel | N. Papageorgiou | N. Sadoul | D. Klug | R. Borgquist | R. Duehmke | R. Ang | C. Reitan | T. Oezkartal | Christian Reitan
[1] P. Neužil,et al. Cardiac Resynchronization Therapy With Wireless Left Ventricular Endocardial Pacing: The SELECT-LV Study. , 2017, Journal of the American College of Cardiology.
[2] P. Lambiase,et al. Is it time to loosen the restrictions on athletes with cardiac disorders competing in sport? , 2017, British Journal of Sports Medicine.
[3] J. Le Heuzey,et al. Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure , 2017, Heart.
[4] Jagmeet P. Singh,et al. Contractility sensor-guided optimization of cardiac resynchronization therapy: results from the RESPOND-CRT trial , 2016, European heart journal.
[5] F. Prinzen,et al. Optimization of left ventricular pacing site plus multipoint pacing improves remodeling and clinical response to cardiac resynchronization therapy at 1 year. , 2016, Heart rhythm.
[6] P. Ponikowski,et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.
[7] P. Lambiase,et al. Primary Prevention Implantable Cardioverter Defibrillator (ICD) Therapy in Women—Data From a Multicenter French Registry , 2016, Journal of the American Heart Association.
[8] B. Zinman,et al. Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes. , 2015, The New England journal of medicine.
[9] G. Boriani,et al. Validation of a simple risk stratification tool for patients implanted with Cardiac Resynchronization Therapy: the VALID‐CRT risk score , 2015, European journal of heart failure.
[10] Akshay S. Desai,et al. Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.
[11] J. Brugada,et al. EAARN score, a predictive score for mortality in patients receiving cardiac resynchronization therapy based on pre-implantation risk factors , 2014, European journal of heart failure.
[12] S. Solomon,et al. The influence of left ventricular ejection fraction on the effectiveness of cardiac resynchronization therapy: MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy). , 2013, Journal of the American College of Cardiology.
[13] J. Daubert,et al. Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure: Results From the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) Study , 2012, Circulation.
[14] S. Solomon,et al. Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. , 2011, Journal of the American College of Cardiology.
[15] Jenq-Wen Huang,et al. Left Ventricular Systolic Strain in Chronic Kidney Disease and Hemodialysis Patients , 2010, American Journal of Nephrology.
[16] B. Tuccillo,et al. Presence of left ventricular contractile reserve predicts midterm response to cardiac resynchronization therapy--results from the LOw dose DObutamine stress-echo test in Cardiac Resynchronization Therapy (LODO-CRT) trial. , 2010, Heart rhythm.
[17] D. Tamborero,et al. Survival in New York Heart Association class IV heart failure patients treated with cardiac resynchronization therapy compared with patients on optimal pharmacological treatment. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[18] N. Obuchowski,et al. Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures , 2010, Epidemiology.
[19] Yvonne Vergouwe,et al. Prognosis and prognostic research: validating a prognostic model , 2009, BMJ : British Medical Journal.
[20] M. LaValley,et al. Logistic Regression , 2008, Circulation.
[21] Jan P Vandenbroucke,et al. The making of STROBE. , 2007, Epidemiology.
[22] Guoqing Diao,et al. Estimation of time‐dependent area under the ROC curve for long‐term risk prediction , 2006, Statistics in medicine.
[23] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[24] J. Le Heuzey,et al. [Recommendations on the implantation and surveillance of implantable defibrillators]. , 2004, Archives des maladies du coeur et des vaisseaux.
[25] D. DeMets,et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, New England Journal of Medicine.
[26] D. Delurgio,et al. Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.
[27] J. Wyatt,et al. Commentary: Prognostic models: clinically useful or quickly forgotten? , 1995 .
[28] S. Saba,et al. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. , 2011, European heart journal.
[29] J. Hilbe. Logistic Regression Models , 2009 .
[30] R. Frank,et al. Recommandations concernant l'implantation et la surveillance des défibrillateurs automatiques implantables. , 2004 .
[31] Willi Sauerbrei,et al. The Use of Resampling Methods to Simplify Regression Models in Medical Statistics , 1999 .
[32] G. Brier. VERIFICATION OF FORECASTS EXPRESSED IN TERMS OF PROBABILITY , 1950 .